Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial  Paul A. Checchia, MD, FCCM, FACC,

Similar presentations


Presentation on theme: "Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial  Paul A. Checchia, MD, FCCM, FACC,"— Presentation transcript:

1 Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial  Paul A. Checchia, MD, FCCM, FACC, Ronald A. Bronicki, MD, Jared T. Muenzer, MD, David Dixon, PhD, Steve Raithel, BS, CCP, Sanjiv K. Gandhi, MD, Charles B. Huddleston, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 146, Issue 3, Pages (September 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 A, Comparison of ventilator hours. B, Comparison of intensive care unit length of stay. P < .05 for both graphs. Solid bar, placebo group; hatched bar, gaseous nitric oxide group. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 A, Comparison of cardiac troponin values. P < .05 at all points. B, Comparison of B-type natriuretic peptide measurements. Solid line, placebo; hatched line, gaseous nitric oxide group. ∗P < .05 at 12- and 24-hour points. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial  Paul A. Checchia, MD, FCCM, FACC,"

Similar presentations


Ads by Google